Investment

Features

Fees Safety

Academy

Pluang+

Home/News Feed/Securities fraud probe hits ADMA Biologics, shares drop 29% in two days

ADMA

$8.79

-$0.08 -0.90%

Securities fraud probe hits ADMA Biologics, shares drop 29% in two days

Market News

26 Mar 2026

Glancy Prongay Wolke & Rotter Llp

View Source

Bearish

ADMA Biologics is under investigation for possible securities fraud following allegations of channel stuffing and undisclosed related party dealings. A report claimed the company induced a distributor to stock excess products by offering rebates and extended payment terms, inflating reported revenue growth. The stock price fell 29.1% over two days, harming investors. A law firm is urging affected shareholders to contact them about potential claims to recover losses, and whistleblowers are encouraged to come forward under the SEC program.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News

Bearish

2 days ago